| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jing Lin | |
| Zhong-Rong Li | |||
| Li-Bin Zhu | |||
| Xiao-Zhong Huang | |||
| P2860 | cites work | Structure, function and diversity of the healthy human microbiome | Q24626370 |
| Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface | Q24644721 | ||
| Interactions between the microbiota and the immune system | Q27028155 | ||
| The human gut microbiome: current knowledge, challenges, and future directions | Q28268561 | ||
| Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota | Q29614272 | ||
| Succession of microbial consortia in the developing infant gut microbiome | Q29615811 | ||
| Interactions between commensal intestinal bacteria and the immune system | Q29617039 | ||
| Recognition of microorganisms and activation of the immune response | Q29617903 | ||
| 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis | Q30860329 | ||
| Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods | Q31113328 | ||
| Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury | Q31136783 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial | Q33440895 | ||
| Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. | Q33609732 | ||
| Molecular modulation of intestinal epithelial barrier: contribution of microbiota | Q33633997 | ||
| Intestinal mucins in colonization and host defense against pathogens | Q33645456 | ||
| Fecal microbiota in premature infants prior to necrotizing enterocolitis | Q33932986 | ||
| Can bacterial interference prevent infection? | Q34090954 | ||
| New Concepts of Microbial Translocation in the Neonatal Intestine: Mechanisms and Prevention | Q34104407 | ||
| Mechanisms controlling pathogen colonization of the gut. | Q34147042 | ||
| Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. | Q34274121 | ||
| Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? | Q34323119 | ||
| Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. | Q34360221 | ||
| Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants | Q34558333 | ||
| Interactions between commensal bacteria and gut sensorimotor function in health and disease | Q34562482 | ||
| Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants | Q34602603 | ||
| The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota | Q34647328 | ||
| Development of the intestinal mucosal barrier | Q34705189 | ||
| The intestinal microbiome and necrotizing enterocolitis | Q34711489 | ||
| Neonatal immune adaptation of the gut and its role during infections | Q34758294 | ||
| Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis | Q35109111 | ||
| Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity | Q35356530 | ||
| Bacterial contributions to mammalian gut development | Q35682785 | ||
| Cellular and physiological effects of probiotics and prebiotics | Q35950418 | ||
| The immunophysiological impact of bacterial CpG DNA on the gut. | Q36253894 | ||
| Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice | Q36375395 | ||
| Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors | Q36384609 | ||
| Probiotics and prebiotics: role in prevention of nosocomial sepsis in preterm infants | Q36569565 | ||
| Epithelial antimicrobial defence of the skin and intestine | Q36584725 | ||
| Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. | Q36646662 | ||
| The altered gut microbiome and necrotizing enterocolitis | Q36660561 | ||
| Necrotising enterocolitis: the state of the science. | Q36722776 | ||
| Intestinal microbial ecology in premature infants assessed with non-culture-based techniques | Q36772933 | ||
| Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism | Q37062373 | ||
| TLRs and innate immunity | Q37100710 | ||
| Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. | Q37159089 | ||
| Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship? | Q37329382 | ||
| Do symbiotic bacteria subvert host immunity? | Q37445498 | ||
| The long-term health effects of neonatal microbial flora | Q37462037 | ||
| Functional biology of intestinal goblet cells | Q37645724 | ||
| Probiotic bacteria and intestinal epithelial barrier function | Q37714234 | ||
| Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates | Q37733964 | ||
| Update on mucosal immunoglobulin A in gastrointestinal disease | Q37778711 | ||
| The developing intestinal microbiome and its relationship to health and disease in the neonate | Q37859258 | ||
| Microbial-induced immunomodulation by targeting the NF-κB system | Q37940024 | ||
| Bacteria and host interactions in the gut epithelial barrier | Q37968876 | ||
| Bacterial colonization and gut development in preterm neonates | Q37979510 | ||
| Composition and roles of intestinal microbiota in children | Q37986166 | ||
| Late onset necrotizing enterocolitis in infants following use of a xanthan gum-containing thickening agent | Q38009097 | ||
| Functions of intestinal microflora in children. | Q38063768 | ||
| Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology | Q39523461 | ||
| Interactions Among Microorganisms of the Indigenous Intestinal Flora and Their Influence on the Host | Q40176255 | ||
| Colonization resistance | Q40285153 | ||
| Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells | Q40333778 | ||
| Gut microbial translocation in critically ill children and effects of supplementation with pre- and pro biotics | Q42014198 | ||
| Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine | Q42033739 | ||
| Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells | Q42058172 | ||
| Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. | Q42151699 | ||
| Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. | Q43067512 | ||
| Total parenteral nutrition adversely affects gut barrier function in neonatal piglets | Q44582154 | ||
| Extraction and purification of biologically active intestinal trefoil factor from human meconium | Q44758851 | ||
| Too much short chain fatty acids cause neonatal necrotizing enterocolitis | Q44764010 | ||
| Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome | Q46677559 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates | Q47370646 | ||
| Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination | Q50119689 | ||
| Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry. | Q50463754 | ||
| Antenatal antibiotic exposure in preterm infants with necrotizing enterocolitis. | Q50506353 | ||
| Microbiota in pediatric inflammatory bowel disease. | Q54432000 | ||
| Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. | Q54486654 | ||
| Low counts of Faecalibacterium prausnitzii in colitis microbiota. | Q54493669 | ||
| Elemental diet and IV-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. | Q54616423 | ||
| Secretory IgA antibody response against Escherichia coli antigens in infants in relation to exposure. | Q54793859 | ||
| IgA-Secreting Cells in the Blood of Premature and Term Infants: Normal Development and Effect of Intrauterine Infections | Q67882962 | ||
| The gut-associated lymphoid system: nature and properties of the large dividing cells | Q68347873 | ||
| Sequential assay of expired breath hydrogen as a means of predicting necrotizing enterocolitis in susceptible infants | Q68966530 | ||
| Breath hydrogen excretion as a screening test for the early diagnosis of necrotizing enterocolitis | Q69176911 | ||
| Total parenteral nutrition promotes bacterial translocation from the gut | Q70397863 | ||
| Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber | Q77754570 | ||
| Role of toll-like receptors in spontaneous commensal-dependent colitis | Q80034254 | ||
| Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal Homeostasis | Q82207962 | ||
| Necrotizing enterocolitis | Q83236511 | ||
| Development of necrotizing enterocolitis in premature infants receiving thickened feeds using SimplyThick® | Q83362526 | ||
| Necrotizing enterocolitis: intraluminal biochemistry in human neonates and a rabbit model | Q93622104 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 46-53 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | World journal of clinical pediatrics | Q27725800 |
| P1476 | title | Bacterial colonization and intestinal mucosal barrier development | |
| P478 | volume | 2 |
| Q97527170 | A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine |
| Q30276871 | Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children |
| Q37704533 | Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet |
| Q92835965 | Expression fusion immunogen by live attenuated Escherichia coli against enterotoxins infection in mice |
| Q35917256 | Gut microbiota and the pathogenesis of necrotizing enterocolitis in preterm neonates |
| Q39818548 | Impact of healthcare-associated sepsis on mortality in critically ill infants |
| Q97882694 | Inhibition of A2B Adenosine Receptor Attenuates Intestinal Injury in a Rat Model of Necrotizing Enterocolitis |
| Q26785532 | Microbiota and the control of blood-tissue barriers |
| Q90039269 | Postnatal pediatric systemic antibiotic episodes during the first three years of life are not associated with mode of delivery |
| Q28085151 | Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci |
| Q64065562 | Prevention of necrotizing enterocolitis in premature infants - an updated review |
| Q35426826 | Reevaluating the hype: four bacterial metabolites under scrutiny |
| Q26801649 | Role of gut microbiota in the modulation of atherosclerosis-associated immune response |
| Q47741625 | Steroids, Stress, and the Gut Microbiome-Brain Axis. |
Search more.